OMNI 3.1 Surgical System in Subjects With Primary Open-Angle Glaucoma
← catalyst calendarNCT06991270 · readout in 11 d
Sponsored by Sight Sciences, Inc. (industry) · SGHT — their whole pipeline →.
Phase
Not applicable
Status
Recruiting
Study type
Interventional
Design
Na · None · Treatment
Enrollment
25estimated
Sites
1
Country
Panama
Every value on this page is a field the sponsor filed with ClinicalTrials.gov, reproduced. Dates are their own estimates, revised as a study runs, unless the registry marks them actual. sources →
Source: ClinicalTrials.gov, retrieved 2026-08-19
Dates
each axis at the precision it was filed, with the registry's own basis| Date | Filed | Basis | What it is |
|---|---|---|---|
| Start | Feb 2026 | estimated | When the study began enrolling |
| Primary completion | 2026-08-31 | estimated | The date the last participant is measured for the primary outcome — the readout window |
| Study completion | May 2027 | estimated | The whole study's end, after follow-up |
| First posted | 2025-05-27 | actual | When this record first appeared on the registry |
| Results posted | — | When the sponsor posted results to the registry | |
| Record updated | 2026-01-14 | actual | The sponsor's own last edit to this record — every projection above is as current as this date |
What it studies
Condition
- Primary Open Angle Glaucoma
Intervention
- Device: OMNI 3.0 Surgical System
Primary outcome
what the primary-completion date above is the date OFPrimary Effectiveness Endpoint
measured 3 months
Permalink · SGHT's whole pipeline · Catalyst calendar · Every registered study · What changed